immunAware ApS
CVR 39189135 · Private limited company (ApS) · Active · Low risk
immunAware ApS is a Private limited company (ApS), founded on , based in Hørsholm. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 8 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 4.9m and a net result of DKK -339k. CEO: Thomas Østerbye, Søren Buus.
Bankruptcy risk for immunAware ApS
0.0 × the average (1.41%) · higher risk than 33% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 39189135
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (8 years)
- Address
- Agern Alle 1
2970 Hørsholm - Municipality
- Rudersdal
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 50k
- Auditor
- Beierholm Godkendt Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 8 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 93.8% |
| Current ratio | 1,313% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 2 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 6 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 4.6m | DKK 4.1m |
| Net profit | DKK -339k | DKK -757k |
| Equity | DKK 4.9m | DKK 5.3m |
| Total assets | DKK 5.2m | DKK 5.8m |
| Cash | DKK 1.7m | – |
| Short-term debt | DKK 328k | – |
| Avg. employees | 9 | – |
Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Beierholm.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 156 | ||
| 1 Jan 2024 – 31 Dec 2024 | 167 | ||
| 1 Jan 2023 – 31 Dec 2023 | 163 | ||
| 1 Jan 2022 – 31 Dec 2022 | 163 | ||
| 1 Jan 2021 – 31 Dec 2021 | 167 | ||
| 1 Jan 2020 – 31 Dec 2020 | 167 | ||
| 1 Jan 2019 – 31 Dec 2019 | 163 | ||
| 19 Dec 2017 – 31 Dec 2018 | 148 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Thomas Østerbye | Current | |
| CEO | Søren Buus | Current | |
| CEO | Anette Stryhn Buus | ||
| Owner (33%) | PROSAL ApS | Current | |
| Owner (25%) | ASTIM Holding ApS | Current | |
| Owner (25%) | T.Ø. Holding ApS | Current | |
| Auditor | Beierholm Godkendt Revisionspartnerselskab | Current | |
| Founder | PROSAL ApS | Current | |
| Founder | ASTIM Holding ApS | Current | |
| Founder | T.Ø. Holding ApS | Current |
The CEOs' other companies
Thomas Østerbye – 1 other companies
- T.Ø. Holding ApS Active
Søren Buus – 1 other companies
- PROSAL ApS Active
Anette Stryhn Buus – 1 other companies
- ASTIM Holding ApS Active
Address history (1 moves)
| Agern Alle 1, 2970 Hørsholm | |
| Floradalen 29, 2830 Virum |
Other companies at the same address
- CysBio ApS Active
- EXPRES2ION BIOTECHNOLOGIES ApS Active
- TANNERMEDICO A/S Active
- TOOsonix A/S Active
- WADeJongh Holding ApS Opløst
- Zaphe ApS Active
Similar companies in Rudersdal
- GigaVax ApS Holte
- Migalis ApS Vedbæk
- LIVAG ApS Vedbæk
- CysBio ApS Hørsholm
- Ceremedy ApS Virum
- Cell to Cure ApS Birkerød
- JKastrup.ApS Birkerød
- ASTIM Holding ApS Birkerød
- ASRØ Holding ApS Nærum
- Detalo Instruments Aps Birkerød
- ResoTher Pharma A/S Holte
- AVP BioPharma Consult ApS Virum
Questions and answers about immunAware ApS
Has immunAware ApS gone bankrupt?
No, immunAware ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of immunAware ApS?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of immunAware ApS?
Thomas Østerbye, Søren Buus are the CEOs of immunAware ApS.
Who is the auditor of immunAware ApS?
immunAware ApS most recently used Beierholm Godkendt Revisionspartnerselskab.
When was immunAware ApS founded?
immunAware ApS was founded on 19 December 2017.
What is the equity of immunAware ApS?
Equity was DKK 4.9m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.